Table 2 Characteristics of the HBV-related decompensated cirrhosis patients
|  | Readmission (n = 36) | Non-Readmission (n = 135) | P Value |
|---|---|---|---|
Male* (%) | 28(77.8%) | 68(68.7%) | 0.303 |
Age (year) | 59(53–61.6) | 58(53–61) | 0.574 |
HBeAg(+)*, n(%) | 27(75%) | 63(63.6%) | 0.215 |
HBsAg | 4122.5(3276.3–6266.0) | 4477.0(3634.0–6326.0) | 0.282 |
HBV-DNA(+)*, n(%) | 27(75%) | 72(72.7%) | 0.792 |
ALT (IU/L) | 72.0(54.3–109.5) | 85.0(65.0–132.0) | 0.105 |
AST (IU/L) | 91.0(55.0–145.5) | 79.0(45.0–114.0) | 0.307 |
TBIL (μmol/L) | 41.4(26.1–67.9) | 39.8(27.0–56.9) | 0.508 |
ALB (g/L) | 30.9(26.7–34.6) | 34.6(32.0–37.9) | 0.042 |
PTA (%) | 70.0(61.3–85.8) | 75.0(63.0–88.0) | 0.233 |
Cr (μmol/L) | 89.0(68.5–93.8) | 73.0(66.0–87.0) | 0.087 |
WBC (109/L) | 4.5(2.9–9.0) | 4.7(3.0–11.4) | 0.807 |
HGB (g/L) | 115.5(89.5–129.8) | 125.0(111.0–137.0) | 0.019 |
PLT (109/L) | 73.5(66.0–123.3) | 90.0(54.0–133.0) | 0.464 |
SBP*, (n,%) | 10(27.8%) | 11(11.1%) | 0.018 |
Ascites*, (n,%) | 31(86.1%) | 81(81.8%) | 0.557 |
GI bleeding*, (n,%) | 15(41.7%) | 12(12.1%) | 0.000 |
HE*, (n,%) | 10(27.8%) | 8(8.1%) | 0.003 |
Child-pugh A/B/C*, n(%) | 0/16/20(0%/44.4%/55.6%) | 0/74/25(0/74.7%/25.3%) | 0.001 |